Colorado Life Sciences Organizations Raise More Than $1B for Seven Consecutive Years
The global impact of life-saving health innovations from Colorado attracts substantial private, public, and government funding. The state’s life sciences ecosystem raised $1.47 billion in 2023, marking the seventh consecutive year of fundraising over $1 billion, after reaching a peak of $2.4 billion in 2021.
Funding Sources
In 2023, federal grants and contracts, the largest source of funding, totaled $560.9 million. Colorado companies raised $499.2 million from public sources and $402.8 million from private sources, primarily venture funding. Pre-Seed through Series B funding increased $52.8 million, demonstrating Colorado’s resilience during challenging times for fundraising.
The state of Colorado offers critical support through robust tax credits for investors and non-dilutive grants for advanced industries companies.
Colorado BioScience Association’s Focus on Capital + Growth
Colorado BioScience Association (CBSA) President & CEO Elyse Blazevich celebrated a strong start to 2024 life sciences fundraising, joining a group of colleagues to ring the New York Stock exchange opening bell in January. CBSA will welcome leading investors to Breckenridge, Colorado during its Rocky Mountain Life Sciences Investor and Partnering Conference in September.
“Our 2023 funding levels, including the increases in early-stage capital, reflect the quality and impact of life-saving innovations from Colorado,” said Blazevich.
